Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • It?s easier to learn words that sound like what they mean

  • First nationwide survey of climate change education

  • Mommy and me: Study shows how affectionate mothering can combat the effects of maternal depression

  • Male biology students consistently underestimate female peers, study finds

  • Will you be turning left or right for that Valentine?s Day kiss: It?ll depend on who you?re kissing!

  • Novel neuroprotective therapy found to enhance memory

  • What 'tainted' engagement rings reveal about consumer expectations

  • Enhancing neuronal activity promotes axon regeneration in adult central nervous system

  • Computerized rehab aids those suffering from brain injuries

  • Lipid-based diets effectively combat Alzheimer's disease in mouse model

  •